人参
免疫
病毒学
免疫系统
医学
转基因小鼠
病毒
鼻腔给药
药理学
效价
接种疫苗
干扰素
生物
免疫学
转基因
微生物学
基因
生物化学
病理
替代医学
标识
DOI:10.31083/j.fbl2706180
摘要
Background: The pandemic caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is ongoing, and despite massive vaccination campaigns, individuals continue to be infected with new SARS-CoV-2 variants. We studied the effects of ginseng, an immune-enhancing agent, on conferring immunity against SARS-CoV-2 in transgenic mice expressing the SARS-CoV-2 human angiotensin-converting enzyme 2 (ACE2) receptor. Methods: Human ACE2-transgenic (ACE2-tg) mice were fed ginseng extract for 180 days before they were intranasally infected with SARS-CoV-2. The mortality and morbidity were monitored for 10 days. The amount of antiviral interferon in the lung tissues was measured using enzyme-linked immunosorbent assay (ELISA) kits. Results: Thirty percent of the mice fed ginseng extract prior to infection survived, whereas all those that were not fed ginseng extract prior to infection died. Viral titers in the lungs were significantly lower in mice fed ginseng extract than in those not fed ginseng extract. The induction of antiviral interferon-gamma (IFN-γ) was significantly higher in the lungs of mice fed ginseng extract than in those that were not. Conclusions: Our data indicate that a ginseng-containing diet may enhance immunity against SARS-CoV-2 in a mouse model.
科研通智能强力驱动
Strongly Powered by AbleSci AI